Vaxcyte PCVX
NASDAQ PCVX
$57.04 +0.35 (+0.62%)
As of: Sep 30, 2026 · 2:53 PM EDT

Vaxcyte (PCVX) Other Operating Expenses (2022 - 2023)

Updated

Vaxcyte's Other Operating Expenses came in at $75 million for Q4 2023, up 226.2% from $23 million a year earlier.

Analysis

Vaxcyte (PCVX) Other Operating Expenses (2022 - 2023) Analysis & Trends

  • Going back by year, Other Operating Expenses was $23 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Vaxcyte 8.21 Bn 8.21 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 75.00 Mn
Dec 31, 2022 23.00 Mn
API Access

Vaxcyte Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=PCVX&period=max&api_key=YOUR_API_KEY